Analytical Data
-
Gene name
NNAT
- Application
-
Alternative Names
Neuronatin; NNAT; NNAT_HUMAN; Peg 5; Peg5
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q16517
-
Expression Region
1-81 aa
-
AA Sequence
MAAVAAASAE LLIIGWYIFR VLLQVFLECC IYWVGFAFRN PPGTQPIARS EVFRYSLQKL AYTVSRTGRQ VLGERRQRAP N
-
Molecular Weight
9.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The NNAT (Neuronal Antigen 1) protein is primarily known for its role in neuronal development and function, and it has garnered research interest due to its potential implications in neurological disorders. NNAT is expressed predominantly in the nervous system and is involved in various cellular processes, including neurogenesis and synaptic plasticity. Its expression patterns are particularly relevant in the context of neurodevelopmental diseases, such as autism spectrum disorders and schizophrenia, where alterations in neuronal differentiation and synaptic connectivity may play crucial roles. Given its significant presence in neuronal tissues, researchers have been investigating the potential of recombinant NNAT proteins for various applications, including as biomarkers for neurological diseases or as targets for therapeutic interventions. The production of recombinant NNAT proteins facilitates the analysis of its functional characteristics, interactions with other neuronal molecules, and contributions to neuronal signaling pathways. Understanding how NNAT functions and its role in neural pathologies can provide insights into developing novel therapeutic strategies aimed at mitigating the effects of these disorders, making NNAT a vital focus of ongoing neurobiological research.
